228 related articles for article (PubMed ID: 9845534)
1. Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1.
Ríus C; Smith JD; Almendro N; Langa C; Botella LM; Marchuk DA; Vary CP; Bernabéu C
Blood; 1998 Dec; 92(12):4677-90. PubMed ID: 9845534
[TBL] [Abstract][Full Text] [Related]
2. Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-beta stimulation.
Botella LM; Sánchez-Elsner T; Rius C; Corbí A; Bernabéu C
J Biol Chem; 2001 Sep; 276(37):34486-94. PubMed ID: 11432852
[TBL] [Abstract][Full Text] [Related]
3. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways.
Sánchez-Elsner T; Botella LM; Velasco B; Langa C; Bernabéu C
J Biol Chem; 2002 Nov; 277(46):43799-808. PubMed ID: 12228247
[TBL] [Abstract][Full Text] [Related]
4. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.
Pece N; Vera S; Cymerman U; White RI; Wrana JL; Letarte M
J Clin Invest; 1997 Nov; 100(10):2568-79. PubMed ID: 9366572
[TBL] [Abstract][Full Text] [Related]
5. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.
Abdalla SA; Pece-Barbara N; Vera S; Tapia E; Paez E; Bernabeu C; Letarte M
Hum Mol Genet; 2000 May; 9(8):1227-37. PubMed ID: 10767348
[TBL] [Abstract][Full Text] [Related]
6. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.
Pece-Barbara N; Cymerman U; Vera S; Marchuk DA; Letarte M
Hum Mol Genet; 1999 Nov; 8(12):2171-81. PubMed ID: 10545596
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury.
Botella LM; Sánchez-Elsner T; Sanz-Rodriguez F; Kojima S; Shimada J; Guerrero-Esteo M; Cooreman MP; Ratziu V; Langa C; Vary CP; Ramirez JR; Friedman S; Bernabéu C
Blood; 2002 Dec; 100(12):4001-10. PubMed ID: 12433697
[TBL] [Abstract][Full Text] [Related]
8. Expression of normal and truncated forms of human endoglin.
Raab U; Velasco B; Lastres P; Letamendía A; Calés C; Langa C; Tapia E; López-Bote JP; Páez E; Bernabéu C
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):579-88. PubMed ID: 10215596
[TBL] [Abstract][Full Text] [Related]
9. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
[TBL] [Abstract][Full Text] [Related]
10. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles.
Gallione CJ; Klaus DJ; Yeh EY; Stenzel TT; Xue Y; Anthony KB; McAllister KA; Baldwin MA; Berg JN; Lux A; Smith JD; Vary CP; Craigen WJ; Westermann CJ; Warner ML; Miller YE; Jackson CE; Guttmacher AE; Marchuk DA
Hum Mutat; 1998; 11(4):286-94. PubMed ID: 9554745
[TBL] [Abstract][Full Text] [Related]
11. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.
McAllister KA; Grogg KM; Johnson DW; Gallione CJ; Baldwin MA; Jackson CE; Helmbold EA; Markel DS; McKinnon WC; Murrell J
Nat Genet; 1994 Dec; 8(4):345-51. PubMed ID: 7894484
[TBL] [Abstract][Full Text] [Related]
12. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
[TBL] [Abstract][Full Text] [Related]
13. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.
Bourdeau A; Faughnan ME; McDonald ML; Paterson AD; Wanless IR; Letarte M
Am J Pathol; 2001 Jun; 158(6):2011-20. PubMed ID: 11395379
[TBL] [Abstract][Full Text] [Related]
14. Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression. Structural and functional characterization.
Almendro N; Bellón T; Rius C; Lastres P; Langa C; Corbí A; Bernabéu C
J Immunol; 1996 Dec; 157(12):5411-21. PubMed ID: 8955189
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
16. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin.
Cymerman U; Vera S; Pece-Barbara N; Bourdeau A; White RI; Dunn J; Letarte M
Pediatr Res; 2000 Jan; 47(1):24-35. PubMed ID: 10625079
[TBL] [Abstract][Full Text] [Related]
17. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.
Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Pérez-Molino A; Hebbel RP; Nguyen J; Bernabéu C; Botella LM
Cardiovasc Res; 2005 Nov; 68(2):235-48. PubMed ID: 15993872
[TBL] [Abstract][Full Text] [Related]
18. Genetic abnormalities in hereditary hemorrhagic telangiectasia.
Marchuk DA
Curr Opin Hematol; 1998 Sep; 5(5):332-8. PubMed ID: 9776212
[TBL] [Abstract][Full Text] [Related]
19. Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function.
Paquet ME; Pece-Barbara N; Vera S; Cymerman U; Karabegovic A; Shovlin C; Letarte M
Hum Mol Genet; 2001 Jun; 10(13):1347-57. PubMed ID: 11440987
[TBL] [Abstract][Full Text] [Related]
20. Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters.
Velasco B; Ramírez JR; Relloso M; Li C; Kumar S; Lopez-Bote JP; Pérez-Barriocanal F; López-Novoa JM; Cowan PJ; d'Apice AJ; Bernabéu C
Gene Ther; 2001 Jun; 8(12):897-904. PubMed ID: 11426329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
